ALKERMES reported 136.21M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.98B 99M
Acadia Pharmaceuticals ACAD:US $ 81.67M 15.12M
Acorda Therapeutics ACOR:US $ 29.62M 2.74M
Amgen AMGN:US $ 1.31B 79M
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bluebird Bio BLUE:US $ 68.28M 10.3M
Bristol Myers Squibb BMY:US $ 1.79B 95M
Coherus Biosciences CHRS:US $ 39.92M 420K
Eli Lilly And LLY:US $ 1.58B 107.8M
Gilead Sciences GILD:US $ 1.18B 173M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
H. Lundbeck A/S LUN:DC 1.59B 15M
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Horizon Pharma HZNP:US 360.26M 5.06M
Intra Cellular Therapies ITCI:US $ 70.5M 646.73K
IONIS PHARMACEUT IONS:US $ 31M 25.46M
JAZZ PHA JAZZ:US 363.68M 65.35M
Johnson & Johnson JNJ:US $ 6B 73M
Marinus Pharmaceuticals MRNS:US 9.45M 2.62M
Merk MRK:US $ 2.27B 9M
Minerva Neurosciences NERV:US $ 3M 437.6K
Nektar Therapeutics NKTR:US $ 29.47M 87K
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Otsuka Holdings 4578:JP 155.96B 7.12B
Pfizer PFE:US $ 2.73B 61M
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Revance Therapeutics RVNC:US $ 51.12M 2.11M
Teva Pharmaceutical Industries TEVA:US 864M 32M
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
Zogenix ZGNX:US $ 39.56M 5.68M